Laxmi Organic Industries Ltd.
Value Pick Multibagger Best Stock for long term investment
Company Overview
Market Cap: ₹6,331 Cr.
Current Price: ₹229
52-Week High/Low: ₹326/₹212
Stock P/E: 46.5
Financial Highlights
Sales (FY24): ₹3,068 Cr.
Profit After Tax (PAT): ₹136 Cr.
ROCE: 9.40%
ROE: 7.36%
Future Growth Drivers
Capacity Expansion
- Launch of India’s first 70KTA n-Butyl Acetate plant at Dahej by Q1 FY26
- New 70KTA ethyl acetate production line at Lote, Maharashtra
- Incremental CAPEX of ₹11,000 Mn across FY25-FY28
Strategic Initiatives
- Focus on fluorospecialties and advanced diketene derivatives
- Aim for 20% revenue contribution from new products by FY28
- Backward integration into raw material production
Financial Projections
Revenue
FY24: ₹28,650 Mn → FY28E: ~₹57,000 Mn
Approximately 2x growth
EBITDA
FY24: ₹2,839 Mn → FY28E: ~₹7,666 Mn
Approximately 2.7x growth
ROCE
Targeted increase from 10% to 20% by FY28
Through efficient capital allocation
Competitive Landscape
Essentials
- Largest domestic producer of ethyl acetate
- Among top 3 global players (ex-China) in acetyl intermediates
Specialties
- Dominant player in diketene derivatives
- Among top 5 globally
- Sole domestic supplier of electrochemical fluorination products
Inherent Risks
Market Risks
- Commodity price fluctuations
- Crude oil derivative dependency
Operational Risks
- Regulatory approval delays
- CAPEX timeline challenges
- Execution risks
External Risks
- Geopolitical trade uncertainties
- Increasing competition
- Export market volatility
Valuation Estimate
Target Price
₹275 – ₹300
Assumes EPS CAGR of ~20%
Valuation Metrics
- Forward P/E: ~40
- Current Stock P/E: 46.5
- Dividend Yield: 0.26%
Investment Thesis
Laxmi Organic Industries Ltd. is a leader in acetyl intermediates and specialty chemicals, with a proven track record of strategic acquisitions and operational excellence. Its focus on innovation, sustainability, and cost efficiency positions it well for robust growth in the next 3-5 years.
With an ambitious plan to double revenues and triple EBITDA by FY28, the company offers significant upside potential for long-term investors.